Cwc Advisors, Llc. Ligand Pharmaceuticals Inc Transaction History
Cwc Advisors, Llc.
- $101 Billion
- Q3 2024
A detailed history of Cwc Advisors, Llc. transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Cwc Advisors, Llc. holds 2,652 shares of LGND stock, worth $282,915. This represents 0.26% of its overall portfolio holdings.
Number of Shares
2,652Holding current value
$282,915% of portfolio
0.26%Shares
1 transactions
Others Institutions Holding LGND
# of Institutions
248Shares Held
17.6MCall Options Held
61KPut Options Held
7.8K-
Black Rock Inc. New York, NY2.87MShares$306 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.93MShares$206 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.01MShares$108 Million0.05% of portfolio
-
Macquarie Group LTD Australia, C3967KShares$103 Million0.1% of portfolio
-
Dimensional Fund Advisors LP Austin, TX709KShares$75.6 Million0.02% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $1.8B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...